We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
-3.27%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$43.7B
AUM Growth
-$654M
Cap. Flow
+$1.55B
Cap. Flow %
3.54%
Top 10 Hldgs %
18.76%
Holding
3,868
New
224
Increased
1,970
Reduced
1,386
Closed
163

Sector Composition

Rank Sector Weight
1 Technology 11.86%
2 Financials 5.98%
3 Healthcare 4.98%
4 Consumer Discretionary 4.84%
5 Industrials 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNMP
3651
DELISTED
Evolve Transition Infrastructure LP
SNMP
$21K ﹤0.01%
1,350
ALZN icon
3652
Alzamend Neuro
ALZN
$5.06M
$20K ﹤0.01%
12
-74
-86% -$139K
FLNT
3653
Fluent
FLNT
$102M
$20K ﹤0.01%
+1,667
New +$17K
NAK
3654
Northern Dynasty Minerals
NAK
$885M
$20K ﹤0.01%
50,550
+12,500
+33% +$4.43K
UPH
3655
DELISTED
UpHealth, Inc.
UPH
$20K ﹤0.01%
1,753
+50
+3% +$1.11K
EVGN icon
3656
Evogene
EVGN
$6.57M
$19K ﹤0.01%
1,472
-50
-3% -$674
HEXO
3657
DELISTED
HEXO Corp. Common Shares
HEXO
$19K ﹤0.01%
2,193
-401
-15% -$3.41K
ARDX icon
3658
Ardelyx
ARDX
$1.24B
$18K ﹤0.01%
+17,100
New +$15.3K
AIFA
3659
All In FutureTech Alliance Inc
AIFA
$12.2M
$17K ﹤0.01%
1,738
AQMS icon
3660
Aqua Metals
AQMS
$9.63M
$16K ﹤0.01%
56
HELP
3661
Cybin Inc
HELP
$472M
$16K ﹤0.01%
545
+207
+61% +$7.56K
DRRX
3662
DELISTED
DURECT Corp
DRRX
$15K ﹤0.01%
2,296
KALA icon
3663
KALA BIO
KALA
$11.8M
$15K ﹤0.01%
5
UBX
3664
DELISTED
Unity Biotechnology
UBX
$15K ﹤0.01%
1,382
-80
-5% -$897
REUN
3665
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$15K ﹤0.01%
2,240
REED
3666
DELISTED
Reeds, Inc. Common Stock
REED
$15K ﹤0.01%
+1,000
New +$15.5K
COCP icon
3667
Cocrystal Pharma
COCP
$12.4M
$14K ﹤0.01%
2,212
GMBL
3668
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$14K ﹤0.01%
+1
New +$85.8K
AMPE
3669
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$14K ﹤0.01%
105
-7
-6% -$1.02K
INFI
3670
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$13K ﹤0.01%
+11,990
New +$14.3K
AGTC
3671
DELISTED
Applied Genetic Technologies Corporation
AGTC
$13K ﹤0.01%
12,664
+2,050
+19% +$3.73K
HEPA
3672
DELISTED
Hepion Pharmaceuticals
HEPA
$12K ﹤0.01%
10
UAMY icon
3673
United States Antimony
UAMY
$766M
$12K ﹤0.01%
18,790
CBIO
3674
Crescent Biopharma
CBIO
$602M
$11K ﹤0.01%
100
THM
3675
International Tower Hill Mines
THM
$534M
$10K ﹤0.01%
+11,000
New +$9.78K

Similar funds

Commonwealth Equity Services's Q1 2022 Portfolio in Review

As of Q1 2022, Commonwealth Equity Services held 3,868 positions worth $43.7B, down 1.5% from $44.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Commonwealth Equity Services deployed $1.55B of net new capital in Q1 2022, opening 224 new positions and adding to 1,970 existing holdings. Its largest new stake was Shell: 319,280 shares worth $17.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $51.8M trimmed.

  • Commonwealth Equity Services's largest Q1 2022 buy was Shell: 319,280 shares worth $17.5M.
  • Commonwealth Equity Services added most to iShares Core S&P 500 ETF in Q1 2022, an estimated $55.2M increase.
  • Commonwealth Equity Services's biggest Q1 2022 reduction was Vanguard Total International Bond ETF, cutting an estimated $51.8M.
  • Commonwealth Equity Services fully exited Xilinx Inc in Q1 2022, selling an estimated $8.28M.
  • Commonwealth Equity Services's ten largest holdings make up 19% of its $43.7B portfolio in Q1 2022.
  • Commonwealth Equity Services opened 224 new positions and closed 163 in Q1 2022.
  • Commonwealth Equity Services's portfolio value fell 1.5% quarter-over-quarter to $43.7B.

Based on Commonwealth Equity Services's 13F filing for Q1 2022, filed 4 May 2022.